About Cell Microsystems
Cell Microsystems is a Healthcare company based in Durham (United States) founded in 2009. Developer of a technology to isolate and recover single cells for molecular analysis. Cell Microsystems has raised $19.1 million across 23 funding rounds from investors including NIH, HHS and NCBiotech. Cell Microsystems has completed 1 acquisition, including Fluxion Biosciences. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Cell Biology. Its competitors include NanoCellect Biomedical, Singulex and LumaCyte; 3 of its 3 listed competitors have raised funding.
Company details
Cell Microsystems was founded in 2009 in Durham, United States, within the biotechnology sector. A proprietary technology is developed to isolate and recover single cells for molecular analysis. The CellRaft AIR system is utilized to track cells, accelerate colony growth, and enable gentle sorting and isolation processes. Operations focus on advancing cell-based research tools for scientific applications.
- Headquarters Durham, United States
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cellmicrosystems.com
- Social X
- Total Equity Funding$19.1M (USD)
in 23 rounds
- Latest Funding Round$6.5M (USD), Series B
Aug 2023
- InvestorsNIH
& 5 more
- Investments & Acquisitions
Funding Insights of Cell Microsystems
Cell Microsystems has successfully raised a total of $19.1M across 23 strategic funding rounds. The most recent funding activity was a Series B round of $6.5 million completed in August 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $19.1M
- Total Rounds 23
- Last Round Series B — $6.5M
- First Round $203,579
(Jul 2009)
- Investors Count 6
Latest 10 of 23 funding rounds of Cell Microsystems with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2023 | $6.5M | Series B | – | Telegraph Hill Partners | – |
| Nov 2021 | $12.6M | Series A | – | Telegraph Hill Partners | – |
| Aug 2021 | $256,605 | Grant | – | – | |
| Mar 2021 | $2.1M | Grant | – | – | |
| Jan 2021 | $1.88M | Grant | – | – | |
| Aug 2020 | $1.22M | Grant | – | – | |
| Jun 2020 | $2.5M | Grant | – | – | |
| Jun 2020 | Debt – Conventional | – | – | ||
| Sep 2019 | $284,132 | Grant | – | – | |
| Jun 2019 | $1.85M | Debt – Conventional | – | – | – |
6 investors in total: 6 institutional.
Investors in Cell Microsystems
Cell Microsystems has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and NCBiotech.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital firm focused on life science, medical device and healthcare companies | thpartners.net | San Francisco, United States | ||
| telegraphhillpartners.com | ||||
Biotech startups are incubated and funded in North Carolina. | 1984 | ncbiotech.org | Durham, United States | |
| sbir.nih.gov | ||||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Public health and human services are overseen by HHS. | 1953 | hhs.gov |
Investor details for Cell Microsystems
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Cell Microsystems
22 people are tracked at Cell Microsystems (8 in leadership, 5 in board & advisors, 9 in team).
| Name | Role | Group |
|---|---|---|
Jessica Hartman | Senior Director, Product Applications | Leadership |
Scott McGinnis | VP, Sales | Leadership |
Gary Pace | CEO | Leadership |
Aaron Kennington | VP, Product Development | Leadership |
Lisa Birkby | Senior Director Of Marketing | Leadership |
Adam Labaff M.s. | Director Of Business Development | Leadership |
Rob McClellan | Director, Software Systems | Leadership |
Steven Gebhart | Director, Engineering | Leadership |
Brett Williams | Director | Board & advisors |
Chris Sims | Director | Board & advisors |
Rob J Capone | Director | Board & advisors |
Alexander C. Herzick | Director | Board & advisors |
Deval A Lashkari | Director | Board & advisors |
Megan S. Harrison | Field Application Scientist, 3d Cell Culture Specialist | Team |
Allysa Stern | Scientist II, Product Applications | Team |
Emily Waters | Office & Accounting Manager | Team |
Lindsey Kuehm | Field Application Scientist | Team |
Brandon Thompson | Senior Manager, Array Products | Team |
Shante Wilcox | Manufacturing Lead | Team |
Caleb Fleming | Research & Development Design Engineer | Team |
2 more people are available in the full profile.
Complete people profiles for Cell Microsystems
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cell Microsystems
Cell Microsystems has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fluxion Biosciences.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Microfluidics-based tools for cellular analysis are provided. | fluxionbio.com | San Francisco, United States | 2005 | Aug 2023 | •••• |
Complete acquisition details for Cell Microsystems
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Cell Microsystems
4 dated milestones of Cell Microsystems across 14 years, from founding to its latest funding, stage changes and deals.
- Founded Cell Microsystems is founded.
- Funding First funding round of $204K.
- Funding Latest funding round, Series B, of $6.5M.
- Acquisition Acquires Fluxion Biosciences.
Competitors of Cell Microsystems
Cell Microsystems has 3 listed competitors in our database, 3 of them funded. They include NanoCellect Biomedical, Singulex and LumaCyte.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| nanocellect.com | 2009 | San Diego, United States | $78.15M | 84 | Develops flow cytometry and cell sorting technology | |
| singulex.com | 1997 | Alameda, United States | $140.94M | 236 | Single-molecule counting technology is developed for cardiovascular biomarker detection. | |
| lumacyte.com | 2012 | Charlottesville, United States | $24.05M | Provider of microfluidic and optics based instruments |
Detailed competitors of Cell Microsystems
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Cell Microsystems
The website of Cell Microsystems (cellmicrosystems.com) receives about 3.4K visits a month.
- Monthly visits3.4K
▼ 2% vs previous month
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Cell Microsystems (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Cell Microsystems
Complete news archive for Cell Microsystems
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cell Microsystems
Cell Microsystems was founded in 2009.
Cell Microsystems is headquartered in Durham, United States. It is registered at Durham, North Carolina, United States.
Cell Microsystems is a funded company, having raised a total of $19.1M across 23 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $1.85M, raised on Jul 2009.
Cell Microsystems was founded in 2009 in Durham, United States, within the biotechnology sector. A proprietary technology is developed to isolate and recover single cells for molecular analysis. The CellRaft AIR system is utilized to track cells, accelerate colony growth, and enable gentle sorting and isolation processes. Operations focus on advancing cell-based research tools for scientific applications.
Cell Microsystems's top competitors include NanoCellect Biomedical, Singulex and LumaCyte.
Cell Microsystems has made 1 acquisition, including Fluxion Biosciences.
Cell Microsystems has 6 investors. Key investors include NIH, HHS, NCBiotech, Telegraph Hill Partners, and Telegraph Hill Partners.